GlassScriptPhysician profile
Michael L Adler
NPI 1568432136
$276,902.79
in general payments reported to CMS, 2019-2025
46 companies · $15K in 2025
The $15K reported for 2025 was more than what 92% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $57K · 2021: $51K · 2022: $54K · 2023: $35K · 2024: $17K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58K · Food and Beverage: $6,668 · Travel and Lodging: $2,716 · Education: $51.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $57,506.94 |
| Food and Beverage | $6,667.77 |
| Travel and Lodging | $2,715.97 |
| Education | $51.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $126,885.95 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $97,121.02 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Abbvie INC. | $23,843.61 | 2019-2025 | Synthroid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17,769.32 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Eli Lilly and Company | $3,737.50 | 2020 | |
| Amgen INC. | $1,057.02 | 2019-2025 | Repatha, Evenity, Prolia |
| Sanofi-Aventis U.S. LLC | $959.57 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $831.49 | 2019-2024 | Farxiga |
| Abbott Laboratories | $464.59 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $437.27 | 2020-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $327.90 | 2022-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $283.91 | 2022-2025 | |
| Tandem Diabetes Care, INC. | $271.18 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novartis Pharmaceuticals Corporation | $268.93 | 2019-2025 | |
| Ibsa Pharma INC. | $174.38 | 2020-2025 | Tirosint, Licart, Tirosint |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $164.05 | 2019-2025 | Korlym |
| Pfizer INC. | $162.61 | 2021-2024 | |
| Radius Health, INC. | $156.66 | 2019-2024 | Tymlos |
| Insulet Corporation | $149.80 | 2019-2024 | Omnipod |
| Merck Sharp & Dohme LLC | $149.62 | 2019-2022 | |
| Antares Pharma, INC. | $148.73 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Cequr Corporation | $146.06 | 2023-2025 | Cequr Simplicity |
| Orthalign INC | $136.39 | 2025 | Orthalign Plus |
| Ascendis Pharma Endocrinology INC | $127.05 | 2023-2025 | Yorvipath |
| Medtronic, INC. | $114.94 | 2023-2025 | Minimed 780g, Inceptiv |
| Tolmar, INC. | $103.43 | 2024-2025 | Jatenzo |
| Alexion Pharmaceuticals, INC. | $102.00 | 2022-2024 | Strensiq |
| Janssen Pharmaceuticals, INC | $85.82 | 2019-2020 | |
| Averitas Pharma INC. | $80.13 | 2024 | Qutenza |
| Esperion Therapeutics, INC. | $78.20 | 2024-2025 | Nexletol |
| Ultragenyx Pharmaceutical INC. | $70.94 | 2021-2022 | |
| Rhythm Pharmaceuticals, INC. | $54.99 | 2025 | Imcivree |
| Opko Pharmaceuticals, LLC | $53.72 | 2019 | |
| Zealand Pharma US, INC. | $50.07 | 2021-2022 | |
| Halozyme INC | $49.02 | 2023 | |
| Shire North American Group INC | $47.99 | 2019 | |
| Madrigal Pharmaceuticals | $45.18 | 2025 | Rezdiffra |
| Kyowa Kirin, INC. | $40.69 | 2024 | Crysvita |
| Amarin Pharma, INC. | $29.64 | 2019-2022 | |
| Mannkind Corporation | $23.66 | 2021 | |
| Eisai INC. | $20.35 | 2019 | |
| Medtronic Minimed, INC. | $19.50 | 2019 | |
| Valeritas, INC. | $17.57 | 2019 | |
| Gilead Sciences, INC. | $14.64 | 2019 | |
| Clarus Therapeutics INC. | $14.46 | 2021 | |
| Biodelivery Sciences International, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Adler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.